# HER2 Expression Detection in Breast Cancer Using 99mTc-NM-02

> **NCT04040686** · EARLY_PHASE1 · COMPLETED · sponsor: **Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 10 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Injection of 99mTc-NM-02

## Key facts

- **NCT ID:** NCT04040686
- **Lead sponsor:** Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-29
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-03-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04040686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04040686, "HER2 Expression Detection in Breast Cancer Using 99mTc-NM-02". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04040686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*